Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1–30) expression is upregulated in diabetes and PEGylated GIP(1–30) can suppress the progression of low-dose-STZ-induced hyperglycaemia…

Overview of attention for article published in Diabetologia, December 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 21,763 followers.

RT @DiabetologiaJnl: Pancreatic GIP(1-30); Therapeutic Potentials to treat Diabetes; Yanagimachi T & Fujita Y. https://t.co/4Fibzic08z

Reply Repost Favourite

RT @DiabetologiaJnl: Pancreatic GIP(1-30); Therapeutic Potentials to treat Diabetes; Yanagimachi T & Fujita Y. https://t.co/4Fibzic08z

Reply Repost Favourite

Pancreatic GIP(1-30); Therapeutic Potentials to treat Diabetes; Yanagimachi T & Fujita Y. https://t.co/4Fibzic08z

Reply Repost Favourite

Pancreatic GIP(1-30); Therapeutic Potentials to treat Diabetes; Yanagimachi T & Fujita Y. https://t.co/4Fibzic08z

Reply Repost Favourite

Pancreatic GIP(1-30); Therapeutic Potentials to treat Diabetes; Yanagimachi T & Fujita Y. https://t.co/4Fibzic08z

Reply Repost Favourite